Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Lungpacer Press Release
Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again.
Read The Article
Lungpacer News
Health-Economic Value of Transvenous Diaphragm Neurostimulation in Ventilator Weaning
Read The Article
Lungpacer Press Release
Lungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients
Read The Article
Lungpacer Press Release
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
Read The Article
Sort by:
IFESS 2010 Conference Presentation, Vienna, Austria
September 10, 2010
Press Release
